Definition

Death [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVGrade 5 Gastrointestinal Disorders - Other, Specify, CTCAE

Clinical finding
- Finding by Cause
  - Adverse Event
    - CTCAE by Body System
      - Gastrointestinal Disorders, CTCAE
        Gastrointestinal Disorders - Other, Specify, CTCAE
        Grade 5 Gastrointestinal Disorders - Other, Specify, CTCAE

Recent clinical studies

Etiology

Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I study.

Hatton MQ, Hill R, Fenwick JD, Morgan SA, Wilson PC, Atherton PJ, Dickson J, Murray KE, Paul J
Radiother Oncol 2016 Mar;118(3):471-7. Epub 2015 Dec 11 doi: 10.1016/j.radonc.2015.11.015. PMID: 26687902

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel.

Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard JY; LUME-Lung 1 Study Group
Lung Cancer 2015 Nov;90(2):267-73. Epub 2015 Aug 12 doi: 10.1016/j.lungcan.2015.08.003. PMID: 26415992

See all (2)

Therapy

Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I study.

Hatton MQ, Hill R, Fenwick JD, Morgan SA, Wilson PC, Atherton PJ, Dickson J, Murray KE, Paul J
Radiother Oncol 2016 Mar;118(3):471-7. Epub 2015 Dec 11 doi: 10.1016/j.radonc.2015.11.015. PMID: 26687902

Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel.

Reck M, Mellemgaard A, von Pawel J, Gottfried M, Bondarenko I, Cheng Y, Zarogoulidis K, Luft A, Bennouna J, Barrueco J, Aboshady H, Hocke J, Kaiser R, Douillard JY; LUME-Lung 1 Study Group
Lung Cancer 2015 Nov;90(2):267-73. Epub 2015 Aug 12 doi: 10.1016/j.lungcan.2015.08.003. PMID: 26415992

See all (2)

Clinical prediction guides

Continuous hyperfractionated accelerated radiotherapy - Escalated dose (CHART-ED): A phase I study.

Hatton MQ, Hill R, Fenwick JD, Morgan SA, Wilson PC, Atherton PJ, Dickson J, Murray KE, Paul J
Radiother Oncol 2016 Mar;118(3):471-7. Epub 2015 Dec 11 doi: 10.1016/j.radonc.2015.11.015. PMID: 26687902

See all (1)

MedGen

National Center for Biotechnology Information

Send to:

Grade 5 Gastrointestinal Disorders - Other, Specify, CTCAE

Definition

Term Hierarchy

Recent clinical studies

Etiology

Therapy

Clinical prediction guides

Supplemental Content

Table of contents

Recent activity